NORTH CHICAGO Ill. Nov. 30 2016 PRNewswire &8212;ÂAbbVie NYSE ABBV a global biopharmaceutical company today announced that the U.S. Food and Drug Administration FDA has granted Orphan Drug Designation to risankizumab ABBV066; formerly BI 655066 for the...
↧